Circadian Variation and Baseline Definition in Parallel-Group Thorough QT Studies

Area of Science:

• Clinical Pharmacology
• Biostatistics
• Cardiovascular Research

Background:

• Thorough QT (TQT) studies are crucial for assessing drug-induced QT interval prolongation.
• Regulatory bodies prefer time-matched baseline corrections to address circadian variations in TQT studies.
• The impact of baseline correction methods on TQT study outcomes requires further investigation.

Purpose of the Study:

• To evaluate the performance of three repeated-measures analysis of covariance (ANCOVA) models in TQT studies.
• To compare the efficacy of time-matched versus time-averaged baseline corrections under various conditions.
• To assess the robustness of ANCOVA models against baseline imbalances and circadian variability.

Main Methods:

• Analysis of historical data from parallel-group TQT studies.
• Simulation of data using assumed circadian models.
• Assessment of three ANCOVA models: time-matched baseline, time-averaged baseline, and combined baselines.

Main Results:

• All tested models adequately performed when no time-matched baseline imbalance was present.
• The model using time-matched baseline as a covariate showed poor performance with baseline imbalance.
• Models incorporating time-averaged baselines (alone or combined) provided unbiased treatment difference estimates and controlled type I error rates, irrespective of baseline imbalance or circadian variations.

Conclusions:

• Analysis models utilizing time-averaged baselines are more robust for TQT studies, especially when baseline imbalances exist.
• The use of time-averaged baselines ensures reliable estimation of drug effects on the QT interval, accounting for circadian rhythms.
• These findings suggest a need to reconsider the strict regulatory preference for time-matched baselines in TQT study analyses.